Metabotropic glutamate receptors (mGluRs) are class C, synaptic G protein-coupled receptors (GPCRs) that contain large extracellular ligand binding domains (LBDs) and form constitutive dimers. Despite the existence of a detailed picture of inter-LBD conformational dynamics and structural snapshots of both isolated domains and full-length receptors, it remains unclear how mGluR activation proceeds at the level of the transmembrane domains (TMDs) and how TMD-targeting allosteric drugs exert their effects. Here we use time-resolved functional and conformational assays to dissect the mechanisms by which allosteric drugs activate and modulate mGluR2. Single-molecule subunit counting and inter-TMD fluorescence resonance energy transfer measurements in living cells reveal LBD-independent conformational rearrangements between TMD dimers during receptor modulation. Using these assays along with functional readouts, we uncover heterogeneity in the magnitude, direction, and the timing of the action of both positive and negative allosteric drugs. Together our experiments lead to a 3-state model of TMD activation, which provides a framework for understanding how inter-subunit rearrangements drive class C GPCR activation.
- Joshua Levitz
- Olaf S Andersen
- Scott C Blanchard
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
- Kenton Jon Swartz, National Institute of Neurological Disorders and Stroke, National Institutes of Health, United States
- Received: January 11, 2019
- Accepted: June 6, 2019
- Accepted Manuscript published: June 7, 2019 (version 1)
© 2019, Gutzeit et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.